This inventor holds 1 USPTO granted patent. Top assignees: Boehringer Mannheim Gmbh, Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E. V. . Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 1999
Title: The Innovations of Hans-Hinrich Althaus
Introduction
Hans-Hinrich Althaus is a notable inventor based in Göttingen, Germany. He has made significant contributions to the field of neuroscience, particularly in the regeneration of oligodendrocytes. His work has implications for treating diseases associated with demyelination of nerve fibers.
Latest Patents
Althaus holds a patent for the "Regeneration of oligodendrocytes." This invention involves a process aimed at improving the regeneration of human oligodendrocytes. The method includes treating oligodendrocytes in cell culture with nerve growth factor (NGF) or its active fragments. Additionally, he has disclosed a composition for treating diseases characterized by demyelination, which contains NGF or its active fragments as the active substance, along with standard pharmaceutical vehicles and auxiliary substances.
Career Highlights
Throughout his career, Althaus has worked with prestigious organizations, including the Max Planck Society for the Advancement of Science and Boehringer Mannheim GmbH. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Althaus has collaborated with notable colleagues, including Ilse Bartke and Jurgen Unger. These partnerships have enriched his research and expanded the impact of his work in the scientific community.
Conclusion
Hans-Hinrich Althaus is a distinguished inventor whose work in the regeneration of oligodendrocytes has the potential to transform treatments for demyelinating diseases. His contributions to neuroscience and collaboration with esteemed colleagues highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile